论文部分内容阅读
目的观察稳心颗粒联合胺碘酮治疗冠心病心律失常患者在临床上的作用及疗效。方法将洛阳市吉利区人民医院2014年2月至2015年2月收治的120例冠心病心律失常患者按照随机抽样法分为试验组和对照组,每组60例。对照组采取临床常规方案进行日常治疗,即只使用胺碘酮。试验组在对照组基础上增加使用稳心颗粒药物联合治疗。治疗前后分别进行心电图检查,对比分析两组患者的治疗成果和主要不良反应及总体有效率。结果治疗后试验组临床总有效率为96.67%,显著高于对照组(55.00%);试验组不良反应发生率为3.33%,显著低于对照组(45.00%),差异均有统计学意义(P<0.05)。结论稳心颗粒合并胺碘酮治疗冠心病心律失常患者可提高临床疗效,同时可以有效降低不良反应发生率,值得临床推广。
Objective To observe the clinical effect and curative effect of Wenxin Granule combined with amiodarone on patients with coronary heart disease and arrhythmia. Methods 120 patients with coronary heart disease and arrhythmia admitted from February 2014 to February 2015 in Geely People’s Hospital of Luoyang City were randomly divided into experimental group and control group, with 60 cases in each group. Control group to take routine clinical routine regimen, that is, only the use of amiodarone. The experimental group in the control group based on the use of Wenxin particles drug combination therapy. Before and after treatment were ECG, comparative analysis of the two groups of patients with treatment and the main adverse reactions and the overall efficiency. Results After treatment, the total effective rate of the experimental group was 96.67%, which was significantly higher than that of the control group (55.00%). The incidence of adverse reactions in the experimental group was 3.33%, which was significantly lower than that of the control group (45.00%), the differences were statistically significant P <0.05). Conclusion Wenxin granules combined with amiodarone in patients with coronary heart disease can improve the clinical efficacy of arrhythmia, and can effectively reduce the incidence of adverse reactions, is worth clinical promotion.